Mac care hospital

Emergency No.

0241 242 2411

Emergency Services

24 x 7

Menu
Book Appointment

Dr. Tushar Patil

Dr. Tushar Patil

DR. TUSHAR VISHVASRAO PATIL
MD (Med), DM (Onco)

AFFILIATIONS

  • Consultant Medical Oncologist and Hematoncologist, Department of Medical Oncology, Sahyadri Speciality Hospital, Pune since 06th September 2010.
  • Consultant Medical Oncologist, Department of Medical Oncology, Jupiter Hospital, Pune.
  • Visiting Medical Oncologist, Bharatiya Snaskriti Darshan Trust’s Integrated Cancer Treatment Centre, Wagholi, Pune since January 2012.
  • Assistant Professor, Department Of Medicine, Bharati Vidyapeeth Medical College and Hospital from 2011 till 2020.
  • Department of Medical Oncology, PD Hinduja National Hospital And Medical Research Centre, Mahim, Mumbai, Worked as Associate consultant from September 1st 2009 to 31st August 2010
  • Department of Medical Oncology, PD Hinduja National Hospital And Medical Research Centre, Mahim, Mumbai, Worked as Associate consultant from September 1st 2009 to 31st August 2010
  • Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, 2008-2009. It is one of the largest Oncology hospitals in India providing comprehensive medical care to thousands of cancer patients.

ACADEMIC QUALIFICATIONS

Degree

Year

Institution Name

Rank & Distinction Certificates

DM (Medical Oncology)

2009

Gujarat Cancer and research Institute, Ahmedabad

Secured 1st rank in Gujarat University

Doctor of Medicine(MD)

2006

Seth G.S. Medical College and K.E.M. Hospital Mumbai, India.

Secured 2nd rank in the Institute

MBBS

2001

B.J. Medical College, Pune, India

Distinction in ENT medicine

HSC Board exam

1996

Central Board Of Secondary Education, Kendriya Vidyalaya No 1, Dehu Road, Pune

2ND In School

PAST EXPERIENCE

The Gujarat Cancer and Research Institute, Ahmedabad is a recognised training centre for cancer education and research by Ministry of Health and Family Welfare, Government of India. Every year nearly 15000 new cancer patients visit the clinics from all over India and neighboring countries. Nearly 80% of these cancer patients receive primary care at the Hospital of which over 70% are treated almost free of any charges. Approximately 500 patients attend the OPD daily for medical advice, comprehensive care or for follow-up treatment

  • Worked as a Senior Registrar in Medical Oncology (17th July 2006 – 31st July 2009)
  • Carried out basic medical research and numerous clinical trials
  • Specialized in medical oncology with experience of work in fields of medical oncology like haematology, pediatric oncology, adult oncology
  • Hematopoietic stem cell transplant unit experience: Worked as registrar for 4 months in hematopoietic stem cell transplant unit of Gujarat Cancer and research Institute during the tenure of super speciality course. Institute performs both autologous and allogeneic transplants for various hematologic (benign and malignant) disorders.
  • The position involves seeing patients in out patient department, looking after patient admissions, taking appropriate management decisions.
  • It also involves performing a variety of diagnostic and therapeutic medical procedures.
  • It also involves seeing patients on follow up and training junior colleagues.
  • As a part of research presented a dissertation on: “A Clinical Profile Of Gastrointestinal Stromal Tumors With Special Reference To Imatinib”

KEM Hospital, Mumbai, India :It is one of the oldest and largest government hospitals in India. It is 1800 bedded hospital catering to about 1.8 million out-patients and 85,000 in-patients annually and providing both basic care and advanced treatment facilities in all fields of medicine and surgery.

  • Trained extensively in the esteemed department of Medicine at K.E.M. Hospital, which examines over 3 lakh patients each year.
  • As a part of research presented a dissertation on: “Macrovascular Manifestations In Scleroderma”
  1. Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer, Kothari R, Doshi M, Chaithanya PK, Ct S, Kumar A, Mallavarapu KM, Nagarkar R, Mahobia V, Bhatt N, Priyadarshini KL, Gogia A, Maksud T, Prasad S, Velavan K, L K R, Ss P, Talreja V, Kalra K, Nemade B, Dastidar AG, Gupta T, Patil T, Bondarde S, Patel P, Gupta S, Biswas G, Vaghela M, Mahato P, Parekh H, Kalloli M, Shetty R, Prakash G, Goel A, Mandal S, Choudhury T, Jain M, Goswami C, H M YK, Mukherjee KK, Shrivastava R, Parmar D. A. Clin Breast Cancer. 2024 Oct;24(7):639-646.e2. doi: 10.1016/j.clbc.2024.07.001. Epub 2024 Jul 10. PMID: 39069436.

  2. Role of a Chemo-Recovery Kit with Ayurvedic formulations – containing coral in managing chemotherapy adverse effects and maintaining quality of life in breast cancer patients. Sardeshmukh S, Deshmukh V, Patil T, Gujar S, Godse V, Kulkarni S, Datar S, Deshpande D, Sardeshmukh N, Bhuvad S, Sardeshmukh B, Chavan S, Gupta V.J Ayurveda Integr Med. 2025 Apr 7;16(2):101012. doi: 10.1016/j.jaim.2024.101012. Epub ahead of print. PMID: 40198955; PMCID: PMC12008519

  3. Selective Adjuvant Ayurvedic Treatment Modulates Immune Response and Oxidative Stress in a Patient with Carcinoma of the Pyriform Fossa, Undergoing Radiotherapy: A Case Study, Deshmukh V, Chiplunkar S, Sardeshmukh S, Patil T, Shinde J, Gupta V, Gujar S, Sardeshmukh N, Pathak S, Chavan S, Pradhan T, Godbole J.Complement Med Res. 2024;31(6):577-591. English. doi: 10.1159/000541254. Epub 2024 Sep 18. PMID: 39293422

  4. Pan-cancer analysis of the spectrum of homologous recombination DNA repair (HRR) pathway genes in the Indian population: A retrospective observational study, Parween, Nasreen††; Gupta, Trisha Dutta††; Subramanyam, Paridhy Vanniya††; Tanwar, Nishtha Ajit Singh; Narayana, Archana S; Hussain, Shabnam; Fathima, Nusrath; Rangan, Saranya; Prakash, Ashwini; Jayaraman, Sharanya; Javle, Vyomesh; Gowda, Pooja; Anju, K; Varghese, Linu; Sreekanthreddy, Peddagangannagari; Nagarkar, Raj1; Chithrathara, G2; Vinusarathy, 3; Ranade, Rohit Raghunath4; Kolluru, Saikrishna5; Srinivasan, Sankar6; Shrestha, Sudip7; Patil, Tushar8; Maniar, Vashisht9; Joshi, Ashish9; Biswas, Sutapa10; Subuddhi, Ganesh Chandra10; Biswas, Ghanashyam10; Thirumalairaj, Raja6; Joshi, Amit11; Rishi, Kshitij D; Goswami, Hitesh M; Veldore, Vidya H, Cancer Research, Statistics, and Treatment 6(4):p 512-525, Oct–Dec 2023. | DOI: 10.4103/crst.crst_260_23

  5. Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India. Ankit Patel, Niraj Bhatt, S. S. Prakash, Ghanashyam Biswas, Rajnish Nagarkar, Bodhisatta Roy, Priyanka Samal, Narendra Agrawal, Sushil Meshram, Ashish Kaushal, C. T. Satheesh, Ravikumar Wategaonkar, Kasi Viswanathan Thiagarajan, Kartikeya Jain, P. Vijayaveeran, Kalyan Mukherjee , Kishore Singh, Tushar Patil, Amit Jain, Tuphan Kanti Dolai, Minish Jain, Sachin Hingmire, Tara Chand Gupta, K. C. Lakshmaiah, Deepan Rajamanickam, Bhushan Nemade, Vikash Goyal, Pinaki Mahato, Sanjeev Kumar Mendiratta & Maulik Doshi, Cancer Chemother Pharmacol 91, 457–468 (2023). https://doi.org/10.1007/s00280-023-04530-x

  6. Effectiveness of combinations of Ayurvedic drugs in alleviating drug toxicity and improving quality of life of cancer patients treated with chemotherapy, Vineeta Deshmukh, Arvind Kulkarni, Sudhir Bhargava, Tushar Patil, Vijay Ramdasi, Sudha Gangal, Vasanti Godse, Shrinivas Datar, Shweta Gujar & Sadanand Sardeshmukh,. Support Care Cancer 22, 3007–3015 (2014). https://doi.org/10.1007/s00520-014-2294-0

  7. Outcome of COVID-19 Infection in Cancer Patients in Pune, South Asian J Cancer 2021; 10(01): 23-27, DOI: 10.1055/s-0041-1731910

  8. Semaphorin 3A Suppresses Tumor Growth and Metastasis in Mice Melanoma Model,Goutam Chakraborty,Santosh Kumar ,Rosalin Mishra ,Tushar V. Patil,Gopal C. Kundu, Published: March 20, 2012, https://doi.org/10.1371/journal.pone.0033633

  9. Poster Presentation at ISMPO Conference ONCOCON 2009, Chennai “ NEUROBLASTOMA AT PEDIATRIC ONCOLOGY CENTRE, GCRI, DATA FROM 2001-2005”

  10. IJMPO (Indian Journal of Medical and Paediatric Oncology); Vol 29 No4, 2008: “Adult Wilms’ Tumour: A Case Report.”

  11. Gujarat Medical Journal; Volume 3, July 2008, issue 7: “REVIEW ARTICLE: Chemotherapy Side Effects and Their management.

  12. Gujarat Medical Journal; Volume 3, July 2008, issue 7: “REVIEW ARTICLE: Hematopoietic Stem Cell Transplantation.

  13. Poster Presentation at ESO Conference 2008, Mumbai “An overview of Primary Extra nodal Non Hodgkin’s lymphoma cases presenting at Gujarat Cancer and Research Institute”

  14. Poster Presentation at ESO Conference 2008, Mumbai “ A retrospective review of allogeneic BMT at Gujarat Cancer and Research Institute”

  15. Poster Presentation at ESO Conference 2008, Mumbai “ Solitary extramedullary lymphoid blastic crisis ( B cell) in Chronic myeloid leukemia, an unusual presentation”

  16. Poster Presentation at ESO Conference 2008, Mumbai “ Philadelphia chromosome positive AML and their outcome- Gujarat Cancer and Research Institute Experience

  17. Oral Presentation at ESO Conference 2008, Mumbai “ A study of cytogenetic markers in newly diagnosed patients of acute myeloid leukemia : Gujarat  Cancer and research institute experience”
Scroll to Top